Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 11/13/18
Due: 11/13/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer | NCT01212627 | Angela Taber MD | user2@example.com | None | 2010-09-30 | 2013-04-30 | 2014-04-30 | - | - | 2025-07-14 |
| BrUOG L301 With Non-Small Cell Lung Cancer and Bone Metastases | NCT02283749 | Angela Taber MD | user2@example.com | None | 2015-09-30 | 2018-11-13 | 2019-11-13 | - | - | 2025-07-14 |